These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1503623)

  • 21. Palmoplantar pustulosis treated with itraconazole: a single, active-arm pilot study.
    V'lckova-Laskoska MT; Caca-Biljanovska NG; Laskoski DS; Kamberova SJ
    Dermatol Ther; 2009; 22(1):85-9. PubMed ID: 19222520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Jumihaidokuto (Shi-Wei-Ba-Du-Tang), a Kampo Formula, Decreases the Disease Activity of Palmoplantar Pustulosis.
    Mizawa M; Makino T; Inami C; Shimizu T
    Dermatol Res Pract; 2016; 2016():4060673. PubMed ID: 27143961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guselkumab for the Treatment of Palmoplantar Pustulosis: A Japanese Perspective.
    Yamamoto T
    Clin Pharmacol; 2021; 13():135-143. PubMed ID: 34188558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Palmoplantar pustulosis: Current understanding of disease definition and pathomechanism.
    Murakami M; Terui T
    J Dermatol Sci; 2020 Apr; 98(1):13-19. PubMed ID: 32201085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guselkumab for the treatment of palmoplantar pustulosis.
    Murakami M
    Expert Opin Biol Ther; 2020 Aug; 20(8):841-852. PubMed ID: 32321322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in palmoplantar pustulosis.
    Brunasso AMG; Massone C
    Fac Rev; 2021; 10():62. PubMed ID: 34409425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Palmoplantar pustular psoriasis: successful therapy with efalizumab after non-response to infliximab.
    Wozel G; Vitéz L; Meurer M
    Acta Dermatovenerol Alp Pannonica Adriat; 2008 Sep; 17(3):133-6. PubMed ID: 18853077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term colchicine for recalcitrant palmoplantar pustulosis: treatment outcome in 3 patients.
    Wong SS; Tan KC; Goh CL
    Cutis; 2001 Sep; 68(3):216-8. PubMed ID: 11579788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics and prevalence of plaque psoriasis in patients with palmoplantar pustulosis.
    Andersen YMF; Augustin M; Petersen J; Hagenström K; Mallbris L; Burge R; Egeberg A
    Br J Dermatol; 2019 Nov; 181(5):976-982. PubMed ID: 30815849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of pustular psoriasis with anakinra: a statistical analysis plan for stage 1 of an adaptive two-staged randomised placebo-controlled trial.
    Cro S; Smith C; Wilson R; Cornelius V
    Trials; 2018 Oct; 19(1):534. PubMed ID: 30285894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adalimumab in the management of palmoplantar psoriasis.
    Ghate JV; Alspaugh CD
    J Drugs Dermatol; 2009 Dec; 8(12):1136-9. PubMed ID: 20027943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dietary habits in Japanese patients with palmoplantar pustulosis.
    Serizawa N; Okazaki S; Otsuka Y; Koto M; Okabe K; Ito M; Morita T; Hoashi T; Saeki H; Abe N; Mori M; Okubo Y; Yano Y; Mitsui H; Kanda N
    J Dermatol; 2021 Mar; 48(3):366-375. PubMed ID: 33404125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biologic therapies associated with development of palmoplantar pustulosis and palmoplantar pustular psoriasis: a systematic review.
    Lu JD; Lytvyn Y; Mufti A; Zaaroura H; Sachdeva M; Kwan S; Abduelmula A; Kim P; Yeung J
    Int J Dermatol; 2023 Jan; 62(1):12-21. PubMed ID: 35128653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of dupilumab in palmoplantar pustulosis treatment highlights the role of Th2 inflammation.
    Zheng YX; Chen XB; Wang ZY; Cai SQ; Zheng M; Koh LF; Common JE; Man XY
    Allergy; 2024 May; 79(5):1361-1364. PubMed ID: 38193274
    [No Abstract]   [Full Text] [Related]  

  • 35. Successful Treatment of a Patient with Pyoderma Gangrenosum, Plaque Psoriasis and Palmoplantar Pustulosis with Adalimumab.
    Chu Y; Liu T; Bai J; Fang H; Qiao J
    Clin Cosmet Investig Dermatol; 2022; 15():1991-1995. PubMed ID: 36164556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pustulotic arthro-osteitis associated with palmoplantar pustulosis.
    Yamamoto T
    J Dermatol; 2013 Nov; 40(11):857-63. PubMed ID: 24127744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Local injection of micro-dose anti-interleukin-17A antibody for palmoplantar pustulosis: A real-world study.
    Xia R; Liu J; Gao Y; Diao Z; Chen D; Zhou C; Zhang Z; Yin Z
    Clin Immunol; 2023 Aug; 253():109694. PubMed ID: 37433424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase III clinical study of maxacalcitol ointment in patients with palmoplantar pustulosis: A randomized, double-blind, placebo-controlled trial.
    Umezawa Y; Nakagawa H; Tamaki K
    J Dermatol; 2016 Mar; 43(3):288-93. PubMed ID: 26282062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-17 receptor A blockade with brodalumab in palmoplantar pustular psoriasis: Report on four cases.
    Pinter A; Wilsmann-Theis D; Peitsch WK; Mössner R
    J Dermatol; 2019 May; 46(5):426-430. PubMed ID: 30786053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pilot study of medium-dose cyclosporine for the treatment of palmoplantar pustulosis complicated with pustulotic arthro-osteitis.
    Hayama K; Inadomi T; Fujisawa D; Terui T
    Eur J Dermatol; 2010; 20(6):758-62. PubMed ID: 21047721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.